In the world of Indian entrepreneurship, many success stories begin with a brilliant idea, a market opportunity, or a disruptive technology. Few, however, begin with a simple observation of a problem affecting millions of people across the country.
For Prashant Tandon, the inspiration came while he was working as a Senior Associate at McKinsey & Company. During his consulting assignments across India, he noticed a recurring challenge: people living in Tier II and Tier III cities struggled to access quality healthcare products and reliable medical information. While metropolitan cities enjoyed better healthcare infrastructure and product availability, smaller towns often faced shortages, misinformation, and inconsistent product quality.
Many professionals would have noted the issue and moved on. Tandon chose a different path. He left behind a lucrative corporate career and embarked on a mission that would eventually transform healthcare accessibility in India and lead to one of the country’s most significant digital healthcare acquisitions.
Today, the company he helped build, 1mg, stands as one of India’s most recognized digital healthcare platforms, serving millions of users every month and playing a pivotal role in the country’s rapidly growing health-tech ecosystem.
In 2007, India was experiencing rapid economic growth. Internet penetration was increasing, e-commerce was beginning to gain traction, and digital platforms were starting to reshape consumer behavior.
Yet healthcare remained fragmented.
Consumers often lacked access to trustworthy information about medicines, nutritional supplements, and wellness products. In smaller cities, finding authentic healthcare products was particularly difficult. Counterfeit goods, limited availability, and poor awareness created barriers that affected everyday health decisions.
Tandon believed technology could bridge this gap.
Rather than building another conventional retail business, he envisioned a platform that would empower consumers with information while also providing access to trusted health products.
This vision became the foundation of Healthkart.
In April 2010, Prashant Tandon launched Healthkart with a small team of just four people.
The initial objective was not merely to sell products online. Instead, the platform aimed to become a trusted destination where consumers could learn about healthcare products, understand their benefits, and make informed decisions.
The strategy proved effective.
Users began visiting the platform to access information related to health and wellness products. As traffic grew and the platform crossed its first million visits, Tandon realized that he had successfully built a community.
The audience was there.
The trust was there.
The next logical step was commerce.
Healthkart began offering products ranging from protein supplements and vitamins to general wellness items. However, unlike many online retailers that focused primarily on volume, Tandon concentrated heavily on quality assurance.
He personally evaluated products and suppliers, ensuring customers received authentic items. The company also established a customer support center where users could receive guidance regarding suitable health products.
This approach created confidence among consumers and differentiated Healthkart from competitors.
The market responded positively.
Within its first year, Healthkart achieved revenues of approximately ₹50 lakh and completed around 30,000 transactions.
Perhaps the most revealing statistic was that nearly 45 percent of sales originated from Tier II and Tier III cities.
This validated Tandon’s original hypothesis.
The healthcare accessibility gap he had identified years earlier was real, and consumers outside major metropolitan areas were actively seeking trustworthy alternatives.
The company’s growth accelerated as awareness increased. Product offerings expanded, customer acquisition improved, and operational capabilities strengthened.
But Tandon recognized that a much larger opportunity existed.
Consumers needed more than supplements and wellness products.
They needed medicines.
To address this larger need, Healthkart diversified into medicine delivery through a new initiative called Healthkart+.
The move represented a major strategic shift.
Unlike nutritional supplements, medicines involved regulatory complexities, prescription requirements, inventory management challenges, and significantly greater responsibility toward consumers.
Yet the demand was enormous.
Millions of Indians struggled to access medicines conveniently, especially in locations where pharmacies offered limited stock or where consumers wanted better transparency regarding pricing and alternatives.
Healthkart+ quickly gained traction.
Customers appreciated the convenience, while the digital platform provided access to extensive medicine information and comparisons that traditional pharmacies often could not.
The initiative demonstrated that online healthcare services could extend well beyond wellness products and become a comprehensive healthcare ecosystem.
As the medicine business expanded, it became increasingly clear that Healthkart’s pharmacy operations required an independent identity.
The medicine delivery segment had evolved into a distinct business with its own operational model, customer base, and growth trajectory.
Prashant Tandon therefore decided to separate the pharmacy division from Healthkart.
In 2015, Healthkart+ was rebranded as 1mg.
The name carried an interesting connection to the company’s early journey, drawing inspiration from the location of its first office on MG Road.
The rebranding marked more than a name change.
It represented the beginning of a focused mission to build India’s most trusted digital healthcare platform.
From the outset, 1mg sought to differentiate itself through information, transparency, and convenience.
The platform launched with a database containing information on approximately 100,000 medicines.
For consumers, this was revolutionary.
Users could search medicines, understand compositions, compare alternatives, review usage information, and gain greater clarity regarding prescriptions.
This knowledge-first approach became one of 1mg’s strongest competitive advantages.
The company also expanded into diagnostics by partnering with laboratories that offered home sample collection services.
Instead of visiting diagnostic centers, consumers could book tests online and have samples collected from their homes.
The convenience resonated strongly with urban professionals, senior citizens, and families seeking easier healthcare experiences.
Geographic expansion followed.
Cities such as Lucknow, Agra, and Kanpur became important growth markets as 1mg expanded its reach beyond major metropolitan regions.
By 2015, the platform had achieved more than 1.5 million downloads, demonstrating growing consumer acceptance of digital healthcare solutions.
As user adoption accelerated, investors began taking notice.
The company’s vision aligned with emerging trends in healthcare digitization, consumer empowerment, and technology-driven service delivery.
1mg attracted investment from prominent institutions including Maverick Capital Ventures, HBM Healthcare Investments, and Sequoia Capital.
The funding enabled the company to strengthen technology infrastructure, expand operations, enhance logistics capabilities, and accelerate customer acquisition.
Importantly, 1mg did not restrict itself to marketplace services.
The company expanded into private-label healthcare products, including nutritional supplements and wellness offerings.
Brands such as MuscleBlaze and Incredio gained significant popularity among health-conscious consumers.
The private-label strategy improved margins while strengthening customer loyalty.
As revenues grew, investor confidence deepened further.
The years that followed witnessed remarkable growth.
In June 2019, 1mg secured a major funding round worth approximately ₹483 crore led by Corisol Holdings and supported by the International Finance Corporation.
The investment reflected growing confidence in India’s digital healthcare future.
By this stage, 1mg was serving tens of millions of users across the country.
The platform had evolved from an online medicine service into a comprehensive healthcare destination offering medicines, diagnostics, consultations, wellness products, and health information.
More than 70 million unique patients had interacted with the platform.
The company achieved a valuation that placed it among India’s leading health-tech ventures.
Market share continued to expand as digital adoption accelerated nationwide.
Consumers increasingly embraced the convenience of ordering medicines online, booking tests digitally, and accessing healthcare information from their smartphones.
1mg was no longer simply participating in the market.
It was helping define it.
By 2020, digital healthcare had become one of India’s most attractive growth sectors.
Large corporations recognized that healthcare technology would play a critical role in the future of consumer services.
Among them was Tata Digital.
The Tata Group had been actively building a comprehensive digital ecosystem encompassing grocery delivery, financial services, consumer products, and digital commerce.
Healthcare represented a crucial missing piece.
The group sought a platform with strong consumer trust, nationwide reach, proven technology, and scalable operations.
1mg fit that profile perfectly.
The company served millions of users, covered thousands of pin codes, generated substantial revenues, and possessed one of the strongest healthcare brands in the country.
For Tata Digital, acquiring 1mg represented an opportunity to accelerate its healthcare ambitions.
For 1mg, the partnership offered resources, scale, and strategic support capable of unlocking the next phase of growth.
On June 10, 2021, one of the most significant announcements in India’s digital healthcare sector became official.
Tata Digital acquired a majority stake of approximately 65 percent in 1mg.
The deal quickly became one of the largest acquisitions undertaken by Tata Digital, second only to its acquisition of BigBasket at the time.
The transaction validated years of disciplined execution, innovation, and persistence by Tandon and his team.
What began as a small startup addressing healthcare access challenges had evolved into a company valuable enough to attract one of India’s most respected business groups.
The acquisition also highlighted the growing importance of health technology within India’s broader digital economy.
Today, 1mg has become a household name for millions of Indians.
The platform serves users across thousands of locations, supports multiple languages, and continues to expand its healthcare offerings.
Its digital ecosystem combines medicine delivery, diagnostic services, health information, wellness products, and healthcare accessibility in a single platform.
The company’s growth reflects larger shifts occurring across India’s healthcare landscape, where technology is increasingly reducing barriers between patients and services.
Yet beyond financial milestones and market share statistics, the most enduring aspect of the story remains the vision that started it all.
Prashant Tandon did not begin his entrepreneurial journey chasing valuations or acquisitions.
He started by attempting to solve a practical problem affecting ordinary people.
His willingness to leave a prestigious consulting career, take calculated risks, and build solutions around consumer needs ultimately created one of India’s most influential healthcare startups.
The acquisition by Tata was not the culmination of the story.
It was recognition of a mission that transformed how millions of Indians access healthcare.
In an era where startup headlines often focus on funding rounds and valuations, Prashant Tandon’s journey offers a different lesson: identify a genuine problem, build trust relentlessly, serve customers consistently, and scale with purpose.
Sometimes, that is enough to build a company that changes an industry.
And occasionally, it is enough to capture the attention of one of India’s largest business groups.
For aspiring entrepreneurs across the country, the story of Prashant Tandon serves as a reminder that transformative businesses often begin not with groundbreaking technology, but with a simple desire to solve a meaningful problem.
That desire helped create 1mg-a platform that reshaped healthcare access in India and became one of the country’s most remarkable digital success stories.
